| Members |
targetComponentId |
| Kaposi's sarcoma - category |
Kaposi sarcoma (morphologic abnormality) |
| Kaposi's sarcoma, morphology |
Kaposi sarcoma (morphologic abnormality) |
| Keeping communication aid by patient |
Position communication aid near subject (procedure) |
| Keeping cosmetic mirror near patient |
Position cosmetic mirror near subject (procedure) |
| Keeping equipment by patient |
Position equipment near subject (procedure) |
| Keratitis bullosa |
Keratitis bullosa |
| Keratoacanthoma - category |
Malignant keratoacanthoma |
| Keratoacanthoma of uncertain behavior |
Malignant keratoacanthoma |
| Keratoderma areata |
Striate palmoplantar keratoderma (disorder) |
| Keratoderma with pachyonychia congenita |
Pachyonychia congenita syndrome |
| Ketorolac trometamol 0.5% conventional release eye solution |
Ketorolac trometamol 5 mg/mL eye drops |
| Ketorolac trometamol 0.5% preservative free ophthalmic solution |
Ketorolac trometamol 5 mg/mL eye drops |
| Ketotifen 1mg capsule |
Ketotifen (as ketotifen fumarate) 1 mg oral capsule |
| Ketotifen 1mg tablet |
Product containing precisely ketotifen (as ketotifen fumarate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
| Ketotifen 1mg/5mL elixir |
Product containing precisely ketotifen (as ketotifen fumarate) 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Ketotifen 1mg/5mL elixir |
Product containing precisely ketotifen (as ketotifen fumarate) 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Ketotifen [antihistamine] |
Product containing ketotifen in oral dose form (medicinal product form) |
| Ketotifen [asthma prophylaxis] |
Product containing ketotifen in oral dose form (medicinal product form) |
| Key lesion |
Primary somatic dysfunction |
| Kidney TNM finding |
American Joint Committee on Cancer allowable value |
| Kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at the time of procedure |
Complication of dialysis |
| Kienbock's disease of adults |
Progressive avascular necrosis of lunate |
| Kinetochore |
Centromere |
| Kingella indologenes |
Suttonella indologenes |
| Klebsiella ornithinolytica |
Raoultella ornithinolytica (organism) |
| Klebsiella planticola |
Raoultella planticola (organism) |
| Klebsiella terrigena |
Raoultella terrigena (organism) |
| Klebsiella trevisanii |
Raoultella planticola (organism) |
| Klippel-Trenaunay-Weber syndrome |
Klippel Trenaunay syndrome (disorder) |
| Kloeckera |
Genus Hanseniaspora (organism) |
| Kloeckera corticis var. pulquensis |
Hanseniaspora valbyensis (organism) |
| Kloeckera species |
Genus Hanseniaspora (organism) |
| Kluyveromyces fragilis |
Kluyveromyces marxianus |
| Knee enthesopathy NOS |
Enthesopathy of knee |
| Knot in cord with compression |
True knot of umbilical cord |
| Knowledge level of traditional therapy |
Knowledge level of complementary therapy (observable entity) |
| Kocuria erythromyxa |
Kocuria rosea |
| Koserella |
Yokenella |
| Koserella species |
Yokenella |
| Koserella trabulsii |
Yokenella regensburgei |
| Kraurosis of anus |
Lichen sclerosus of anus |
| Krebs cycle pathway |
Krebs cycle pathway |
| Krupin tube shunt |
Valved ophthalmic drainage device (physical object) |
| Kuhnt-Junius degeneration |
Exudative age-related macular degeneration (disorder) |
| Kyrle's disease |
Hyperkeratosis follicularis in cutem penetrans |
| L-Glutamine 5g powder for oral solution |
Product containing only glutamine (medicinal product) |
| L-asparaginase 10,000iu powder for injection solution 10mL vial |
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| L4/S1 disc |
Structure of intervertebral disc of L5 and S1 (body structure) |
| Lab specimen submitted |
Laboratory specimen submitted |
| Labial flap |
Flap (substance) |
| Labial veneer, laminate, chairside |
Insertion of direct composite veneer onto labial surface of tooth (procedure) |
| Labial veneer, porcelain laminate, laboratory |
Fixation of porcelain veneer onto labial surface of tooth (procedure) |
| Labial veneer, resin laminate, laboratory |
Fixation of indirect resin veneer onto labial surface of tooth (procedure) |
| Laboratory animal dander allergy |
Allergy to animal protein |
| Laboratory fur-bearing animal |
Class Mammalia (organism) |
| Laboratory test panel |
Laboratory test |
| Labourer |
Laborer |
| Laceration of brain without open intracranial wound |
Laceration of brain |
| Laceration of heart with open wound into thorax AND without penetration of heart chambers |
Laceration of heart |
| Laceration of heart without penetration of heart chambers |
Laceration of heart |
| Laceration without prolapse or loss of intraocular tissue of bilateral eyes |
Laceration of eye |
| Lacrimal apparatus implantation |
Operation on lacrimal system |
| Lacrimal apparatus incision |
Operation on lacrimal system |
| Lacrimal duct catheterised |
Catheterization of nasolacrimal duct |
| Lacrimal duct catheterized |
Catheterization of nasolacrimal duct |
| Lacrimal passage granuloma |
Lacrimal sac granuloma |
| Lactation: [problems] or [& obstetric breast disorders NOS]) |
Disorder of lactation |
| Lactobacillus bavaricus (organism) |
Legionella maceachernii |
| Lactobacillus bavaricus |
Latilactobacillus sakei |
| Lactobacillus casei rhamnosus |
Lacticaseibacillus zeae (organism) |
| Lactobacillus cellobiosus |
Limosilactobacillus fermentum (organism) |
| Lactobacillus durianis |
Paucilactobacillus vaccinostercus |
| Lactobacillus halotolerans |
Weissella halotolerans |
| Lactobacillus heterohiochii |
Fructilactobacillus fructivorans |
| Lactobacillus homohiochii |
Fructilactobacillus fructivorans |
| Lactobacillus kandleri |
Weissella kandleri |
| Lactobacillus maltaromicus |
Carnobacterium maltaromaticum (organism) |
| Lactobacillus minor |
Weissella minor |
| Lactobacillus minutus |
Atopobium minutum |
| Lactobacillus trichodes |
Fructilactobacillus fructivorans |
| Lactobacillus viridescens |
Weissella viridescens |
| Lactobacillus yamanashiensis |
Liquorilactobacillus mali (organism) |
| Lactosphaera pasteurii |
Trichococcus pasteurii (organism) |
| Lactulose 10g/15mL syrup |
Product containing precisely lactulose 667 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Laminopathy type Decaudain Vigouroux |
Familial partial lipodystrophy type 2 (disorder) |
| Lamotrigine 200mg dispersible tablet |
Lamotrigine 200 mg orodispersible tablet |
| Lamotrigine 25mg chewable dispersible tablet |
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| Lamotrigine 2mg |
Lamotrigine only product in oral dose form |
| Lamotrigine 2mg chewable dispersible tablet |
Lamotrigine only product in oral dose form |
| Lamotrigine 2mg tablet for conventional release oral suspension |
Lamotrigine only product in oral dose form |
| Lamotrigine 50mg dispersible tablet |
Lamotrigine 50 mg orodispersible tablet |
| Lamotrigine 5mg chewable dispersible tablet |
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) |
| Lamotrigine 5mg chewable tablet |
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) |
| Lamotrigine 5mg tablet for conventional release oral suspension |
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) |
| Langerhans cell histiocytosis - category |
Langerhans' cell histiocytosis |
| Language not given - patient refused |
Refusal by patient to provide information about spoken language (situation) |
| Language not given - patient refused |
Refusal by patient to provide information about spoken language (situation) |
| Language not given - patient refused |
Refusal by patient to provide information about spoken language (situation) |
| Lansoprazole 15mg gastro-resistant tablet |
Lansoprazole 15 mg orodispersible tablet |
| Lansoprazole 30mg gastro-resistant tablet |
Lansoprazole 30 mg orodispersible tablet |
| Lanthanum carbonate 1g chewable tablet |
Lanthanum (as lanthanum carbonate) 1 g chewable tablet |
FHIR